We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Idelalisib

Australian Public Assessment Report

AusPAR

Australian Public Assessment Report for Idelalisib [PDF, 2.71 MB]

Australian Public Assessment Report for Idelalisib [Word, 2.68 MB]

AusPAR Attachment 1: Product Information for Idelalisib [PDF, 251.21 KB]

AusPAR Attachment 1: Product Information for Idelalisib [Word, 244.5 KB]

AusPAR Attachment 2: Extract from the Clinical Evaluation Report for Idelalisib [PDF, 5.9 MB]

AusPAR Attachment 2: Extract from the Clinical Evaluation Report for Idelalisib [Word, 7.01 MB]

Device/Product Name

Zydelig

Active ingredients

Idelalisib

AusPAR Date

14 July 2015

Published

6 August 2015

Submission Number

PM-2013-04151-1-4

Submission Type

New chemical entity

Decision

Approved